NCT03162562 2020-12-22The Safety and Antitumor Activity of the Combination of Oregovomab and Hiltonol in Recurrent Advanced Ovarian CancerCanariaBio Inc.Phase 1 Terminated10 enrolled
NCT03597282 2020-09-03A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced MelanomaBioNTech SEPhase 1 Terminated22 enrolled
NCT02413827 2017-04-07A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV MelanomaCelldex TherapeuticsPhase 1/2 Terminated9 enrolled